Financial report interval: 2025.12.31 - 2026.03.31
Preview: HUADONG MEDICINE(000963) predict that the Revenue is 11.18 B (+4.17%), Miss estimate;the EBIT is 1.2 B (+5.99%), Beat estimate;the EPS is 0.572 (+9.63%), Miss estimate.